John Chiste - Sep 23, 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Director
Signature
/s/ Dale S. Bergman as attorney-in-fact for John Chiste
Stock symbol
OCEL
Transactions as of
Sep 23, 2022
Transactions value $
$0
Form type
3
Date filed
10/11/2022, 08:07 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Warrants to Purchase Common Stock Sep 23, 2022 Common Stock, par value $0.001 1M $0.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Warrants vest in 12 monthly installments of 83,333 shares commencing on September 23, 2022.

Remarks:

Exhibit List - Exhibit 24 Power of attorney